EDITOR'S NOTE
About these case studies
These cases are based on our engagements. To protect confidentiality, we give only industries and size bands, withholding company names and identifying figures. The effects described are the results of individual engagements and do not guarantee similar outcomes.
CASE STUDIES
Our case studies
Generic drug manufacturer (about 800 employees)
Returning to normal shipments
The client approached us after shipments of key products were restricted, with no clear route to recovery.
We combined capacity allocation, expected arrivals of active pharmaceutical ingredients and demand recovery scenarios into one plan, enabling monthly decisions on which products to return to normal shipments and in what order.
We also documented the criteria for imposing and lifting restrictions and standardized explanations to sales teams.

Japan subsidiary of an innovative drug manufacturer (annual sales of ¥40-49.9 billion)
Establishing monthly planning meetings
Demand plans used head office templates that did not align with domestic supply constraints.
We redesigned the monthly meeting in Japan so demand, supply and finance teams could decide using the same figures.
Incorporating remaining shelf life into inventory valuation reduced expiry-related disposal costs by more than 30% year on year.

Regional pharmaceutical wholesaler (annual sales of about ¥90 billion)
Reducing returns and disposal
A pharmaceutical wholesaler, a distributor supplying pharmacies and healthcare providers, had seen almost no improvement in return rates for years and could not set priorities.
Breaking returns down by origin and reason revealed that most costs came from a small number of product groups and particular trading conditions, allowing targeted operational changes.
We also moved inventory-day management from branch level to product-group level to detect slow-moving stock earlier.

Medical device manufacturer (about 300 employees)
Identification codes and loan inventory visibility
Packaging identification codes were in place, but loan inventory held at healthcare institutions did not match the ledger.
We established procedures to reconcile shipping records and loan ledgers and designed a process to flag stock nearing expiry automatically.
We tested the time required to identify affected products in a recall through practical exercises.

Dispensing pharmacy chain (120 stores)
Automated ordering and stock transfers
Ordering depended on each store's experience, causing stockouts and excess inventory within the same chain.
We classified products by turnover, separated automatic ordering from decisions requiring human judgment, and defined criteria and procedures for transfers between stores.
For products with unstable supply, we added a process to register substitute candidates in advance.

CDMO (about 450 employees)
More accurate capacity planning
Frequent changes in client demand created a gap between reserved manufacturing capacity and actual utilization at this contract development and manufacturing organization (CDMO).
We analyzed each client's historical changes and introduced phased capacity commitments based on demand confidence.
For projects undergoing technology transfer, we established a common progress reporting format to reduce rework in client reporting.

NEXT ACTION
Discuss an assessment
Tell us about your supply chain and its challenges.
Discuss an assessment